Cellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate biosynthesis to control cell growth remain largely unknown. Hypoxia-inducible factor-1α (HIF1α) can suppress tumor cell proliferation. Here, we discovered that HIF1α acts as a direct repressor of aspartate biosynthesis involving the suppression of several key aspartate-producing proteins, including cytosolic glutamic-oxaloacetic transaminase-1 (GOT1) and mitochondrial GOT2. Accordingly, HIF1α suppresses aspartate production from both glutamine oxidation as well as the glutamine reductive pathway. Strikingly, the addition of aspartate to the culture medium is sufficient to relieve HIF1α-dependent repression of tumor cell proliferation. Furthermo...
International audienceThe hypoxia-inducible factor (HIF-1), in addition to genetic and epigenetic ch...
HIF-1α modulates energy metabolism in cancer cells by modifying the status of glycolytic enzyme
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer...
Cellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate bi...
SummaryMany cancer cells are characterized by increased glycolysis and decreased respiration, even u...
Hypoxia inducible factor 1 alpha (HIF1α) is a transcription factor that is frequently stabilized and...
Background: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below ...
SummaryHypoxia-inducible factor 1 (HIF-1) mediates a metabolic switch that blocks the conversion of ...
SummaryRecent reports have identified a phenomenon by which hypoxia shifts glutamine metabolism from...
Hypoxia-inducible factor 1 (HIF-1) mediates a metabolic switch that blocks the conversion of pyruvat...
The mitochondrial electron transport chain (ETC) enables many metabolic processes, but why its inhib...
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer...
The ability of cells to adapt to changes in oxygen (O2) levels is essential for normal development a...
Hypoxia Inducible Factors (HIFs) are αβ heterodimeric transcription factors that regulate important ...
Abstract Background Hypoxia signaling, especially the hypoxia inducible factor (HIF) pathway, is a m...
International audienceThe hypoxia-inducible factor (HIF-1), in addition to genetic and epigenetic ch...
HIF-1α modulates energy metabolism in cancer cells by modifying the status of glycolytic enzyme
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer...
Cellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate bi...
SummaryMany cancer cells are characterized by increased glycolysis and decreased respiration, even u...
Hypoxia inducible factor 1 alpha (HIF1α) is a transcription factor that is frequently stabilized and...
Background: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below ...
SummaryHypoxia-inducible factor 1 (HIF-1) mediates a metabolic switch that blocks the conversion of ...
SummaryRecent reports have identified a phenomenon by which hypoxia shifts glutamine metabolism from...
Hypoxia-inducible factor 1 (HIF-1) mediates a metabolic switch that blocks the conversion of pyruvat...
The mitochondrial electron transport chain (ETC) enables many metabolic processes, but why its inhib...
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer...
The ability of cells to adapt to changes in oxygen (O2) levels is essential for normal development a...
Hypoxia Inducible Factors (HIFs) are αβ heterodimeric transcription factors that regulate important ...
Abstract Background Hypoxia signaling, especially the hypoxia inducible factor (HIF) pathway, is a m...
International audienceThe hypoxia-inducible factor (HIF-1), in addition to genetic and epigenetic ch...
HIF-1α modulates energy metabolism in cancer cells by modifying the status of glycolytic enzyme
A better understanding of the metabolic constraints of a tumor may lead to more effective anticancer...